A Phase 3 interventional study of Tamsulosin and Cetirizine in Lower Ureteric Stones, sponsored by South Valley University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-31.
Sponsored by South Valley University · Phase 3, Interventional, and Treatment
we investigate the Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination with Alpha Blockers in distal ureter stone
Exclusion Criteria:
All patients of group A received tamsulosin 0.4 mg once daily
Drug: Tamsulosin
All patients of group B received Cetirizine once daily
Drug: Cetirizine
All patients of group C received Tamsulosin 0.4 mg and Cetirizine once daily
Combination Product: Cetirizine + Tamsulosin
All patients of group D received Placebo once daily
Other: Placebo
group A take tamsulosin once daily
give cetirizine once dailly
both once daily
once dailly
ureter stone free rate
Time frame: 4 weeks
Plan to share: Yes
Supporting information: Csr
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
South Valley University